Asset Management Group’s Biogen BIIB Stock Holding History

Asset Management Group’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-632	Closed	-$201K	–	106
2017 Q4	$201K	Buy	+632	New	+$203K	0.07%	104
2016 Q4	–	Sell	-650	Closed	-$203K	–	102
2016 Q3	$203K	Buy	+650	New	+$193K	0.08%	99
2015 Q3	–	Sell	-650	Closed	-$263K	–	100
2015 Q2	$263K	Hold	650	–	–	0.12%	88
2015 Q1	$274K	Hold	650	–	–	0.13%	85
2014 Q4	$221K	Hold	650	–	–	0.11%	85
2014 Q3	$215K	Hold	650	–	–	0.11%	83
2014 Q2	$205K	Buy	+650	New	+$196K	0.11%	79

Other funds holding BIIB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Asset Management Group's BIIB Position: Q1 2018 in Review

Asset Management Group sold out of Biogen (BIIB) in Q1 2018, closing a stake of 632 shares — an estimated $201K sold.

Asset Management Group first reported a position in BIIB in Q2 2014 and held it in 7 quarters. The position peaked at $274K in Q1 2015. 1,103 funds tracked by Wall St. Rank hold BIIB as of Q1 2018.

Asset Management Group reported no remaining Biogen position as of Q1 2018 after selling out during the quarter.
Asset Management Group sold 632 Biogen shares in Q1 2018, an estimated $201K.
Asset Management Group first reported a position in Biogen in Q2 2014 and held it in 7 quarters.
Asset Management Group's Biogen position peaked at $274K in Q1 2015.
1,103 funds tracked by Wall St. Rank held Biogen as of Q1 2018.

Based on Asset Management Group's 13F filing for Q1 2018, filed 15 May 2018.